NeuroPace, Inc.
- NPCE
- NASDAQ
- Medical devices
- Neuromodulation (Epilepsy)
- Brain Implant (RNS System)
$12.24
Today −4.23%Quote Oct 16, 2026, 08:00 PM UTC
−13.50%over the last month
Max drawdown −16.8%From 1-month high −16.8%3 months −22.3%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Market value
$420.1M
Quote Oct 16
Next earnings
Nov 3
Expected, not confirmed
Analyst target
$20.25
+65.4% from here
Floor
$12.17
0.5% below price
Where the price sits
10 analysts
Analyst range, low to high
$18.00$22.00
- Price $12.24
- Resistance $12.40–$12.52
- Consensus $20.25
The price is just above its floor and right under resistance. Analysts' average target sits about 65% higher.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about NPCEPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days freeWhere the money comes from
No revenue split by segment on file.
Industry
Medical devices
Employees
220
Founded
1997